Morgan Stanley, Polaris
The CEO also said he is ‘bullish’ on the potential for stock sales, including initial public offerings in 2025.
Morgan Stanley analyst Terence Flynn maintained a Buy rating on Regeneron (REGN – Research Report) today and set a price target of $1,185.00.
Morgan Stanley's profit more than doubled in the fourth quarter, fueled by a wave of dealmaking and stock sales that drove ...
Ozempic doesn't just reduce weight. Research shows GLP-1s also changes how much people spend on food, and the types of food ...
Shares of cosmetics company e.l.f. Beauty (NYSE:ELF) fell 5.9% in the afternoon session after research by Morgan Stanley ...
Hosted on MSN7h
Morgan Stanley Upgrades Qorvo (QRVO)Fintel reports that on January 21, 2025, Morgan Stanley upgraded their outlook for Qorvo (NasdaqGS:QRVO) from Equal-Weight to ...
The investment banking giant has been the subject of regulatory probes regarding the way it vets prospective clients. So far, ...
With a TikTok ban potentially set to take effect in the U.S. on Sunday, other social media platforms could compete for its ...
Profits at Bank of America (BAC) and Morgan Stanley (MS) more than doubled in the fourth quarter, signaling a strong 2024 for ...
Morgan Stanley said its profit more than doubled in the fourth quarter, fueled by its investment banking and trading ...
Morgan Stanley easily beat fourth-quarter profit and revenue estimates on strong equity trading and IPO activity.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback